Global Custom Market Research Reports Provider Company

phone

Mateon Therapeutics Inc (MATN) - Financial and Strategic SWOT Analysis Review

  • Published Date: 13 Nov 2017
  • Number of Pages: 25
  • Category: Healthcare and Medical
  • Country: United States of America
Summary

Mateon Therapeutics Inc (Mateon), formerly OXiGENE Inc is a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology indications. The company develops therapeutics to treat cancer and eye diseases; and anti-vascular drugs such as vascular disrupting agents. It is developing a product for treatment of anaplastic thyroid cancer, medullary thyroid cancer, stage IV papillary thyroid cancer, ovarian cancer, and stage IV follicular thyroid cancer. Mateons development pipeline include CA4P and Oxi4503. The company also conducts multiple clinical trials in oncology to discover small-molecule anticancer agents belongs to benzosuberene class of compound. It operates through researchers in the University of Florida and the University of Arhus on anti-angiogenic and anti-metastatic agents. Oxigene is headquartered in San Francisco, California, the US.

Mateon Therapeutics Inc Key Recent Developments

Aug 02,2017: Mateon Provides Corporate Update and Reports Second Quarter 2017 Financial Results
Jun 12,2017: Mateon Therapeutics Provides Update on Its Clinical Trial Programs and Milestones
May 08,2017: Mateon Provides Corporate Update and Reports First Quarter 2017 Financial Results
Mar 30,2017: Mateon Therapeutics Reviews 2016 Highlights and Reports 2016 Financial Results
Nov 14,2016: Mateon Provides Corporate Update and Reports Third Quarter 2016 Financial Results

This comprehensive SWOT profile of Mateon Therapeutics Inc provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Mateon Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,



- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief Summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.



Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,



You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.



Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.



Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.



Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.



Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Publisher Name : GlobalData
Table of Contents


Section 1 - About the Company



Mateon Therapeutics Inc - Key Information

Mateon Therapeutics Inc - Overview

Mateon Therapeutics Inc - Key Employees

Mateon Therapeutics Inc - Key Employee Biographies

Mateon Therapeutics Inc - Key Operational Heads

Mateon Therapeutics Inc - Major Products and Services

Mateon Therapeutics Inc - History

Mateon Therapeutics Inc - Company Statement

Mateon Therapeutics Inc - Locations And Subsidiaries

Mateon Therapeutics Inc - Key Manufacturing facilities

Head Office

Other Locations & Subsidiaries



Section 2 - Company Analysis



Mateon Therapeutics Inc - Business Description

Mateon Therapeutics Inc - Corporate Strategy

Mateon Therapeutics Inc - SWOT Analysis

SWOT Analysis - Overview

Mateon Therapeutics Inc - Strengths

Mateon Therapeutics Inc - Weaknesses

Mateon Therapeutics Inc - Opportunities

Mateon Therapeutics Inc - Threats

Mateon Therapeutics Inc - Key Competitors



Section 3 - Company Financial Performance Charts



Mateon Therapeutics Inc - Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts



Section 4 - Appendix



Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer





Note*: Some sections may be missing if data is unavailable for the company

List Of Tables




Mateon Therapeutics Inc, Key Information

Mateon Therapeutics Inc, Key Ratios

Mateon Therapeutics Inc, Share Data

Mateon Therapeutics Inc, Major Products and Services

Mateon Therapeutics Inc, History

Mateon Therapeutics Inc, Key Employees

Mateon Therapeutics Inc, Key Employee Biographies

Mateon Therapeutics Inc, Key Operational Heads

Mateon Therapeutics Inc, Other Locations

Mateon Therapeutics Inc, Subsidiaries

Mateon Therapeutics Inc, Key Manufacturing facilities

Mateon Therapeutics Inc, Key Competitors

Mateon Therapeutics Inc, SWOT Analysis

Mateon Therapeutics Inc, Ratios based on current share price

Mateon Therapeutics Inc, Annual Ratios

Mateon Therapeutics Inc, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List Of Figures




Mateon Therapeutics Inc, Performance Chart

Mateon Therapeutics Inc, Ratio Charts

Mateon Therapeutics Inc (Mateon), formerly OXiGENE Inc is a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology indications. The company develops therapeutics to treat cancer and eye

View Report

Mateon Therapeutics Inc (Mateon), formerly OXiGENE Inc is a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology indications. The company develops therapeutics to treat cancer and eye

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports